The induction of interferon in chick embryo cells by human adenovirus types I, 5 and 12 has been examined. Rifampicin, at a concentration of I oo/~g./ml., added either immediately or within 24 hr after infection, completely inhibited interferon induction by all three adenoviruses. Up to 24 hr after infection, the inhibitory effect was reversible, and when the drug was removed, interferon production resumed. Rifampicin at IOO #g./ml. also inhibited interferon induction by Semliki Forest virus in chick cells at 37 ° and 42o , although it had no effect on virus growth at 37 °. We conclude that the antibiotic inhibits either a non-essential virus function involved in induction, or alternatively a cellular function. The antiviral action of chick cell interferon against Semliki Forest virus or vaccinia virus was not affected by rifampicin. The drug inhibited chick cell growth, but did not appear to injure cell viability over 48 to 72 hr periods. Rifanlpicin significantly depressed the incorporation of [~H]-thymidine into chick cell DNA, but had a much lesser effect on incorporation of [aH]-uridine and [3H]-leucine into RNA and protein respectively. Downloaded from www.microbiologyresearch.org by
INTRODUCTION
The antibiotic rifampicin blocks bacterial growth by inhibiting the bacterial DNAdependent RNA polymerase (Wehrli et aL 1968 a; Sippel & Hartmann, 1968) . This antibiotic also inhibits the growth of vaccinia and other poxviruses and certain but not all adenoviruses (Heller et al. 1969; Subak-Sharpe, Timbury & Williams, I969; Subak-Sharpe et al. 197o ). In the case of vaccinia, the drug appears to have little or no effect on the virus particleassociated DNA-dependent RNA polymerase activity (Moss, Katz & Rosenblum, I969a; McAuslan, 1969) , and may act by blocking virus assembly (Moss et al. 1969 b) . Except at very high doses rifampicin has no effect on the activity of RNA polymerase from nuclei of mammalian cells (Wehrli et al. I968 b; Jacob, Sajdel & Munro, I968) , but there is evidence that the drug inhibits mitochondrial RNA polymerase isolated from rat liver cells (Gadaleta, Greco & Saccone, I97o) . There are conflicting reports concerning the effect of rifampicin on the growth of mammalian and avian cells. On the one hand it has been reported that antiviral doses of the drug do not inhibit the growth of normal mouse and chick embryo cells (Heller et aL I969; Heller, I97O; Diggelmann & Weissmann, I969; Vaheri & Hanafusa, I97I) , but do inhibit growth of transformed chick embryo cells (Vaheri & Hanafusa, I97I) . On the other hand it has been shown that such doses of rifampicin inhibit growth of BHK 21 cells (Subak-Sharpe et aL 1969; Williams et aL I97I) and of both normal and transformed chick embryo cells (Robinson & Robinson, I97I).
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Recently, it has been reported that rifampicin inhibits the humoral and the cellular immunological response in vivo and in vitro (P~unescu, 1970) . We now present experimental evidence that a virus-induced cellular response, namely interferon production, is reversibly depressed by rifampicin.
METHODS

Viruses.
Adenovirus type I and type 5 stocks were prepared on HeLa cell monolayers and titrated on these as previously described (Williams, I97O) . Adenovirus type I2 stocks were grown on both KB and HeLa cells and titrated on both cell types. Semliki Forest virus and vaccinia virus stocks were prepared on BHK 2I]CI 3 cells, and were titrated both on these cells, and on primary or secondary chick embryo fibroblasts (CEF). The CEF were prepared from Io-day-old embryos (eggs obtained from Poultry Research Association, Edinburgh) by a standard procedure, and were grown in Eagle's medium (Glasgow modification) supplemented with Io % calf serum and IO % tryptose phosphate broth.
Interferon production. To induce interferon by adenoviruses, primary CEF cells seeded 2 to 3 days previously were infected at a m.o.i, of 2o. Eagle's medium supplemented with 2 °/o calf serum was added after infection, and the infected cultures were then incubated at 37 °. Culture fluid was harvested at various times after infection, debris removed by centrifugation for IO min. at 3oo0 rev./min, and samples were then heated at 56o for 3o min. to inactivate residual virus. Interferon was produced at two different temperatures in CEF infected with Semliki Forest virus (Burke, Skehel & Low, 1967) . For induction at 37 °, CEF cells were infected at a m.o.i, ofo'5 to I-O, and at 420 at a m.o.i, of 50 to 8o (both adsorbed at 37°). Culture fluids were harvested 18 to 22 hr after infection, and then treated as described above.
Assay of interferon.
Interferon was usually assayed by measuring the inhibition of plaque formation by vaccinia virus on CEF cells, and occasionally by inhibition of Semliki Forest virus plaque formation or virus yields on CEF. In all cases, samples from each experiment were titrated at the same time. The interferon titre is expressed as the PDD 50 -the reciprocal of the dilution causing a 5o % depression of the control plaque count. One ml. of this dilution contains I unit of interferon.
Measurement of cell DNA, RNA and protein synthesis. To measure cell DNA synthesis in primary CEF cells [SH]-thymidine 0o #c.[ml.) was added for I hr intervals at various times from o to 72 hr to cultures of cells growing on glass coverslips in the presence or absence of rifampicin. After each I hr pulse period, the coverslip cultures were washed twice in phosphate buffered saline, fixed with formol saline, extracted with 5 % trichloroacetic acid, washed thoroughly with water, dried in ethanol, and the radioactivity determined using a liquid scintillation counter.
To determine cell RNA synthesis the incorporation of [3H]-uridine (IO #c./ml.) was measured in such cultures during the same time periods described for DNA. Cell protein synthesis was determined as the incorporation of [~H]-leucine 0o#c./ml.) into such cells during these time periods.
Rifampicin. This was the gift of Lepetit Pharmaceutical Ltd. (Slough). It was prepared as a stock solution of I mg./ml, in distilled water and stored frozen for periods of up to three weeks prior to use.
RESULTS
Induction of interferon synthesis by adenovirus in CEF
The kinetics of interferon synthesis in primary or secondary CEF cells infected by adenovirus, types I, 5 and I2, have been examined in detail. All three adenox~iruses induced 
I4I
interferon at the same rate in primary CEF cells infected at a m.o.i, of 20. At a multiplicity of I adenovirus type I failed to produce interferon, and at a multiplicity of 5 adenovirus types 5 and 12 failed to do so. Interferon first appeared in the medium I2 to I5 hr after infection, increased in concentration over the next 4 ° to 5o hr and attained maximum levels (I28 to 256 PDD 50) within 60 to 7o hr. Typical experimental results using adenovirus type 5 are shown in Fig. L The interferon produced under these conditions was found to be stable to pH 2, sensitive to trypsin, non-inactivable by adenovirus neutralizing antiserum, and species-specific. These results are essentially in agreement with those of B61~idi & Pusztai 0967) and Ho & Kohler (I967), as are our findings that these adenoviruses do not replicate in chick embryo cells. As shown in Fig. I , we find that infectivity gradually decreases after infection.
Pre-treatment of CEF cells with lO units of interferon for I2 to I8 hr prior to infection with adenoviruses resulted in earlier and enhanced production of interferon and up to eightfold higher titres were obtained (see Table 2 ). This priming action has been reported for interferon induction with other viruses (Isaacs & Burke, I958; Lockart, I963; Stewart, Gosser & Lockart, I971), but to our knowledge not previously for the adenoviruses.
Effect of rifampicin on adenovirus-induced interferon synthesis
Previous experiments showed that rifampicin at Ioo/zg./ml. depressed the replication of types I, 2 and 5 in HeLa cells (Subak-Sharpe et al. I97O ), but subsequently we have found that growth of adenovirus type Iz in HeLa cells was not affected by the drug (Table I ). The reason for this different response is not understood. Despite the fact that none of these adenoviruses replicate in chick cells, these findings led us to examine the effect of rifampicin on interferon induction by different adenoviruses in CEF.
Preliminary experiments showed that treatment for 2 to 5 days after infection with I oo #g./ ml. rifampicin completely depressed interferon synthesis in CEF infected with adenovirus types I, 5 and I2. This effect is illustrated for type 5 in Table 2 ). The addition of rifampicin at any time up to 24 hr after infection results in a complete inhibition of interferon production (Table 3 ) while later addition results in a reduced effect. On the other hand, withdrawal of the drug at times up to 24 hr after addition in both primed or non-primed cells resulted in complete recovery of interferon production showing that the inhibition is reversible. In these experiments, medium was removed at the various times indicated, and fresh medium either with or without rifampicin was added. At times later than 24 hr post-infection the ceils had already released interferon into the medium (column 4 in Table 3 ), so that the resulting final levels attained (at 5 days) were lower.
Effect of rifampiein on synthesis of interferon induced by Semliki Forest virus
The effect of rifampicin on both growth of Semliki Forest virus and production of interferon at 37 ° was examined simultaneously in the same CEF cultures. In addition, the effect of the drug was examined on interferon production in infected cells infected at 37 ° and IP: 54.70.40.11
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Rifampicin depression of interferon production I43 * Pre-treated with Io units of interferon. All samples were finally collected at 5 days. The titres in columns 2 and 3 thus represent the levels of interferon produced between the time of addition or removal of rifampicin and 5 days. incubated at 420 , where no infectious virus was produced. The results of one such experiment are shown in Table 4 , where it can be seen that rifampicin had no effect on the growth of Semliki Forest virus in CEF, while ~oo/zg./ml. of the drug caused an eightfold depression of interferon production at either temperature during the 20 hr period following infection.
Lack of effect of rifampicin on the antiviral activity of interferon
The antibiotic actinomycin D inhibits both production and action of interferon (Taylor, 1965) . In view of the inhibition of interferon production by rifampicin, it was important to determine if interferon action was also affected by rifampicin treatment. However, unlike actinomycin D, rifampicin (at Too #g./ml.) had no detectable effect on the antiviral activity of chick interferon on the growth of both Semliki Forest virus (Table 5 ) and vaccinia in CEF cells.
Inhibition of CEF cell growth by rifampicin
It was important to determine if CEF cell growth was inhibited by rifampicin under our culture conditions, as well as to determine if the cell viability was irreversibly damaged by the drug. In many experiments we have consistently found that 75 to IOO/zg./ml. rifampicin prevented the growth of chick embryo cells seeded on 5o mm. dishes at initial concentrations of 2 to 5 × Io o cells/dish (2o to 3o % of these cells adhere). Even 5o #g./ml. partially depressed cell growth (Fig. 3) Rifampicin depression of interferon production 145 0"85 0"44 * IO cells were seeded on to 50 mm. plastic dishes containing IO ' irradiated rat embryo feeder cells in 5 ml. of Eagle's medium+ 5 ~ calf serum. Cultures were incubated for 7 days and stained with Giemsa for counting. We have investigated the reversibility of the effect of rifampicin in two ways. First, in terms of the colony-forming ability (plating-efficiency) of cells, and second, in terms of the growth rate of the cells. The plating-efficiency of CEF ceils treated for 2 days with Ioo #g.[ ml. of rifampicin did not seem to differ very much from that of control, non-treated cells (Table 6 ). In addition, the growth rates of rifampicin-treated (2 to 3 days) and non-treated cells seeded at IO 6 cetls/dish were found to be identical. These findings taken together with the fact that the CEF cells remained healthy in appearance for up to 5 days in the presence of Ioo #g,/ml. rifampicin indicate that treatment of CEF cells for 2 to 3 days with rifampicin did not result in general cell death. Thus, one cannot account for the depression of interferon synthesis simply in terms of cell killing, unless interferon is synthesized by a small, special class of CEF which is particularly sensitive to rifampicin. However, even allowing for the existence of such a class of CEF, the possibility that rifampicin selectively acts in a lethal way on them seems most unlikely, in view of the fact that the rifampicin block is reversible, and CEF cells treated for up to 24 hr produce normal levels of interferon on removal of the drug.
Effect of rifampicin on macromolecular synthesis by CEF cells
The doses of rifampicin used in the present experiments have been previously reported to exert very little effect on incorporation of radioactive precursors into cellular DNA, RNA and proteins of mouse cells (Heller et al. I969), or chick cells (Heller, 197o ) . On the other The values in the table are the ratios of the average counts per minute per coverslip for the rifampicin treated cells compared with the non-treated control cells. All values represent means for two separate coverslips, and the lowest average count]min./coverslip for the controls was 41o7.
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S. USTACELEBI AND J. F. WILLIAMS hand, incorporation of [aH]-thymidine into the DNA of partially synchronized BHK 2I cells is inhibited to some extent . In order to establish the case for CEF cells under the conditions used in the interferon experiments, we have examined the uptake of [3H]-thymidine, [~H]-uridine and [ZH]-leucine into cell DNA, RNA and protein in the presence and the absence of rifampicin. The results of one such experiment in which the relevant precursors were present for I hr periods at intervals up to 72 hr after the addition of rifampicin are shown in Table 7 -The greatest effect was on incorporation of [aH]-thymidine -which was reduced by 8o % in the first 24 hr, and by a further I o % in the next 24 hr period. The incorporation of [3H]-uridine and [ZH]-leucine was depressed to a much lesser extent up to 48 hr even by too/zg./ml, but in the 48 to 72 hr period following was depressed by as much as 85 %.
Thus, while our data for incorporation of [~H]-uridine and [3H]-leucine agree more closely with Heller, our findings with [*H]-thymidine do not. It should be pointed out that these comparisons are only strictly valid for the first 24 hr of treatment, since Heller's published experiments terminated 24 hr after addition of rifampicin.
DISCUSSION
The differential inhibition of adenovirus growth in human cells by rifampicin suggested that these viruses might also exhibit exploitable differences with respect to interferon induction in CEF cells, despite the fact they fail to undergo a complete replication cycle in these cells. However, we found that interferon induction by adenovirus types I, 5 and I2 was inhibited by rifampicin, and that interferon induction in CEF by Semliki Forest virus, whose growth in these same cells was not inhibited by rifampicin, was also depressed by the drug. This makes it most unlikely that an essential virus function is the target for rifampicin, and suggests that either a non-essential virus function or a cellular function involved in interferon induction is inhibited by the drug.
At present very little is known concerning the action of rifampicin on avian and mammalian cell functions. Our data confirm that CEF multiplication is adversely affected by rifampicin, but despite growth inhibition, the cells remain viable for at least 2 to 3 days in the presence of Ioo #g./ml. of the drug, as has been reported for BHK 2I cells (Subak-Sharpe et al. I969). Concerning the period after infection during which interferon is induced, synthesized and released from CEF cells into the medium, namely, o to 48 hr, the only measurable effect of rifampicin on cell macromolecular synthesis is the inhibition of the incorporation of [aH]-tiaymidine into DNA. This finding could be taken to imply that both cell growth and interferon depression in CEF cells treated with rifampicin result from inhibition of cell DNA synthesis. The apparent effect on DNA synthesis need not be direct but may, of course, stem from the action of the drug on some other cell function(s), which could also be the cause of cell growth inhibition and interferon synthesis. There is little effect during this period on RNA and protein synthesis. Should rifampicin act during this initial 48 hr period at the transcriptional level in CEF, it presumably therefore only prevents transcription of certain classes of mRNA. It has been reported that rifampicin inhibits mammalian mitochondrial RNA polymerase in vitro (Gadaleta et al. ~97o ), but not the nuclear activity (Wehrli et al. 1968 b; Jacob et al. 1968; Gadaleta et al. I97O) . While there is no evidence that rifampicin acts in the same way in intact CEF cells, these findings raise the possibility that interferon synthesis may be directed by mitochondrial rather than nuclear DNA. In view of this possibility, it will be important to determine if rifampicin preferentially inhibits mitochondrial RNA synthesis in CEF cells. In this respect it is of interest that a compound On: Fri, 28 Dec 2018 01:30:43
Rifampiein depression of interferon production I47 related to rifampicin, AF/ABDP, causes morphological changes in the mitochondria of CEF cells (E. A. C. Follett, personal communication). Of course, it is possible that mitochondrial damage relating to a mitochondrial function such as oxidative phosphorylation could be the cause of the depression of interferon synthesis in CEF. Rifampicin inhibits at least two 'induced' cellular functions, the immune response (Pgtunescu, 197o) , and interferon induction. In addition, it inhibits transformation of chick cells by Rous sarcoma virus (Diggelmann & Weissmann, 1969) , and transformation of rifampicin resistant BHK 2I cells by polyoma virus (Williams et aL I971) both of which might involve 'turning on' or induction of certain cell functions as a direct or an indirect result of the introduction of virus genes. Thus it is intriguing to speculate that rifampicin might act somewhat preferentially, though not exclusively to inhibit such induced cell functions.
While we do not know if rifampicin inhibits interferon induction in vivo, we consider that this work, and that of Paunescu 0970) raises an important practical issue concerning the possible use of rifampicin and related compounds as antiviral agents in vivo. Clearly, at the high doses necessary for antiviral activity they will not only block virus growth but may also depress the natural defence mechanisms of the body against the target virus, and other foreign agents, and the implication of these effects will have to be taken into account.
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